Tailor Bio
London, England, United Kingdom
About Tailor Bio
Tailor Bio develops an AI-driven drug discovery platform for pan-cancer medicine by decoding chromosomal instability. They respond to customer inquiries by email.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: Seed
- Last round: Seed (Nov 2022)
- Website: tailor.bio
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Consulting, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/tailor-bio-2538302 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.